Increased Heart Rate and Haemostatic Balance Disorders Pre-exist the Established Hypertension

Increased Heart Rate and Haemostatic Balance Disorders Pre-exist the Established Hypertension -

[1]  K. Kavaklı,et al.  Plasma Platelet-activating Factor (PAF) Levels and Desmopressin Response in Children with Hemophilia A and von Willebrand's Disease , 1999, Thrombosis and Haemostasis.

[2]  G. Siest,et al.  Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[3]  G. Lip,et al.  Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. , 1997, The American journal of cardiology.

[4]  A. Rumley,et al.  Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[5]  T. Makris,et al.  Haemostasis balance disorders in patients with essential hypertension. , 1997, Thrombosis research.

[6]  S. Julius,et al.  Heart rate and the cardiovascular risk , 1997, Journal of hypertension.

[7]  I. Mattiasson,et al.  Coagulation and fibrinolytic factors in normotensive hypertension-prone men , 1996, Journal of hypertension.

[8]  J. Zehnder,et al.  Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[9]  P. Simioni,et al.  “Pseudo Homozygous” Activated Protein C Resistance due to Double Heterozygous Factor V Defects (Factor V Leiden Mutation and Type I Quantitative Factor V Defect) Associated with Thrombosis: Report of Two Cases Belonging to Two Unrelated Kindreds , 1996, Thrombosis and Haemostasis.

[10]  P. Lund-johansen,et al.  The Bergen Blood Pressure Study: prehypertensive changes in cardiac structure and function in offspring of hypertensive families. , 1995, Blood pressure.

[11]  B. Dahlbäck,et al.  Activated protein C resistance: from phenotype to genotype and clinical practice. , 1995, Blood reviews.

[12]  M. Woodward,et al.  Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. , 1993, British heart journal.

[13]  J. Feldman,et al.  Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. , 1991, American heart journal.

[14]  U. Smith,et al.  Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease , 1990, Journal of internal medicine.